BACKGROUND: In most tuberculosis (TB) endemic countries, bacillus Calmette-Guérin (BCG) is usually given around birth to prevent severe TB in infants. The neonatal immune system is immature. Our hypothesis was that delaying BCG vaccination from birth to 10 weeks of age would enhance the vaccine-induced immune response. METHODS: In a randomized clinical trial, BCG was administered intradermally either at birth (n=25) or at 10 weeks of age (n=21). Ten weeks after vaccination, and at 1 year of age, vaccine-specific CD4 and CD8 T cell responses were measured with a whole blood intracellular cytokine assay. RESULTS: Infants who received delayed BCG vaccination demonstrated higher frequencies of BCG-specific CD4 T cells, particularly polyfunctional T cells co-expressing IFN-gamma, TNF-alpha and IL-2, and most strikingly at 1 year of age. CONCLUSIONS: Delaying BCG vaccination from birth to 10 weeks of age enhances the quantitative and qualitative BCG-specific T cell response, when measured at 1 year of age.
RCT Entities:
BACKGROUND: In most tuberculosis (TB) endemic countries, bacillus Calmette-Guérin (BCG) is usually given around birth to prevent severe TB in infants. The neonatal immune system is immature. Our hypothesis was that delaying BCG vaccination from birth to 10 weeks of age would enhance the vaccine-induced immune response. METHODS: In a randomized clinical trial, BCG was administered intradermally either at birth (n=25) or at 10 weeks of age (n=21). Ten weeks after vaccination, and at 1 year of age, vaccine-specific CD4 and CD8 T cell responses were measured with a whole blood intracellular cytokine assay. RESULTS:Infants who received delayed BCG vaccination demonstrated higher frequencies of BCG-specific CD4 T cells, particularly polyfunctional T cells co-expressing IFN-gamma, TNF-alpha and IL-2, and most strikingly at 1 year of age. CONCLUSIONS: Delaying BCG vaccination from birth to 10 weeks of age enhances the quantitative and qualitative BCG-specific T cell response, when measured at 1 year of age.
Authors: O M S Dantas; R A de A Ximenes; M de F P M de Albuquerque; N L C L da Silva; U R Montarroyos; W V de Souza; T C C Pereira; A R L Campelo; L C Rodrigues Journal: Int J Tuberc Lung Dis Date: 2006-05 Impact factor: 2.373
Authors: Patricia Gorak-Stolinska; Rosemary E Weir; Sian Floyd; Maeve K Lalor; Sally Stenson; Keith Branson; Rose Blitz; Sarah Luke; Bernadette Nazareth; Anne Ben-Smith; Paul E M Fine; Hazel M Dockrell Journal: Vaccine Date: 2006-05-08 Impact factor: 3.641
Authors: A Marchant; T Goetghebuer; M O Ota; I Wolfe; S J Ceesay; D De Groote; T Corrah; S Bennett; J Wheeler; K Huygen; P Aaby; K P McAdam; M J Newport Journal: J Immunol Date: 1999-08-15 Impact factor: 5.422
Authors: Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup Journal: Blood Date: 2006-02-07 Impact factor: 22.113
Authors: Andreia P Soares; Cheong K C Kwong Chung; Terry Choice; E Jane Hughes; Gail Jacobs; Esme Janse van Rensburg; Gloria Khomba; Marwou de Kock; Lesedi Lerumo; Lebohang Makhethe; Mbulelo H Maneli; Bernadette Pienaar; Erica Smit; Nontobeko G Tena-Coki; Leandre van Wyk; W Henry Boom; Gilla Kaplan; Thomas J Scriba; Willem A Hanekom Journal: J Infect Dis Date: 2013-01-04 Impact factor: 5.226
Authors: C Ponte; L Peres; S Marinho; J Lima; M Siqueira; T Pedro; P De Luca; C Cascabulho; L R Castello-Branco; P R Z Antas Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452
Authors: Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom Journal: Eur J Immunol Date: 2010-01 Impact factor: 5.532
Authors: Anna K Blakney; Christophe Toukam Tchakoute; Anneke C Hesseling; Elvis B Kidzeru; Christine E Jones; Jo-Ann S Passmore; Donald L Sodora; Clive M Gray; Heather B Jaspan Journal: Vaccine Date: 2015-08-07 Impact factor: 3.641